Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Literature DB >> 4852619

Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

I Odar-Cederlöf, O Borgå.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1974 PMID： 4852619 DOI： 10.1007/bf00614387

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

× No keyword cloud information.

15 in total

1. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors: M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal: N Engl J Med Date: 1971-07-29 Impact factor: 91.245

2. Abnormal pharmacokinetics of phenytoin in a patient with uraemia.

Authors: I Odar-Cederlöf; P Lunde; F Sjöqvist
Journal: Lancet Date: 1970-10-17 Impact factor: 79.321

Review 3. Treatment of arrhythmias: basic considerations.

Authors: K C Lasseter
Journal: Med Clin North Am Date: 1971-03 Impact factor: 5.456

4. Recent myocardial infarction and the conduction system. A clinico-pathological correlation.

Authors: L G Ekelund; A Moberg; A G Olsson; L Orö
Journal: Br Heart J Date: 1972-08

5. Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Authors: N Gerber; J G Wagner
Journal: Res Commun Chem Pathol Pharmacol Date: 1972-05

6. Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.

Authors: A Berlin; S Agurell; O Borgå; L Lund; F Sjöqvist
Journal: Scand J Clin Lab Invest Date: 1972-05 Impact factor: 1.713

7. Kinetics of diphenylhydantoin disposition in man.

Authors: T Suzuki; Y Saito; K Nishihara
Journal: Chem Pharm Bull (Tokyo) Date: 1970-02 Impact factor: 1.645

8. Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors: M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal: Eur J Clin Pharmacol Date: 1971-09 Impact factor: 2.953

9. Effect of mode of administration on drug distribution in a two-compartment open system.

Authors: M Gibaldi
Journal: J Pharm Sci Date: 1969-03 Impact factor: 3.534

10. Volume terms in pharmacokinetics.

Authors: L Z Benet; R A Ronfeld
Journal: J Pharm Sci Date: 1969-05 Impact factor: 3.534

40 in total

1. Drug kinetics and artificial kidneys.

Authors: T B Gibson; H A Nelson
Journal: Clin Pharmacokinet Date: 1977 Nov-Dec Impact factor: 6.447

Review 2. Therapeutic drug monitoring in saliva.

Authors: M Danhof; D D Breimer
Journal: Clin Pharmacokinet Date: 1978 Jan-Feb Impact factor: 6.447

3. [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors: H Kurz
Journal: Klin Wochenschr Date: 1978-12-15

4. Propranolol disposition in renal failure.

Authors: A J Wood; R E Vestal; C L Spannuth; W J Stone; G R Wilkinson; D G Shand
Journal: Br J Clin Pharmacol Date: 1980-12 Impact factor: 4.335

5. Comparative pharmacokinetics of diminazene in noninfected Boran (Bos indicus) cattle and Boran cattle infected with Trypanosoma congolense.

Authors: M Mamman; Y O Aliu; A S Peregrine
Journal: Antimicrob Agents Chemother Date: 1993-05 Impact factor: 5.191

6. Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.

Authors: R Gugler; G Mueller
Journal: Br J Clin Pharmacol Date: 1978-05 Impact factor: 4.335

7. Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentration.

Authors: M Ehrnebo; I Odar-Cederlöf
Journal: Eur J Clin Pharmacol Date: 1977 Impact factor: 2.953